Ophthalmic Research Laboratories, Central Adelaide Local Health Network, Level 7 Adelaide Health & Medical Sciences Building, University of Adelaide, Adelaide, South Australia, Australia; Department of Ophthalmology and Visual Sciences, University of Adelaide, Adelaide, South Australia, Australia.
Mol Cell Neurosci. 2018 Apr;88:270-291. doi: 10.1016/j.mcn.2018.01.002. Epub 2018 Mar 20.
Glaucoma is a leading cause of irreversible blindness manifesting as an age-related, progressive optic neuropathy with associated retinal ganglion cell (RGC) loss. Mitogen-activated protein kinases (MAPKs: p42/44 MAPK, SAPK/JNK, p38 MAPK) are activated in various retinal disease models and likely contribute to the mechanisms of RGC death. Although MAPKs play roles in the development of retinal pathology, their action in the optic nerve head (ONH), where the initial insult to RGC axons likely resides in glaucoma, remains unexplored.
An experimental paradigm representing glaucoma was established by induction of chronic ocular hypertension (OHT) via laser-induced coagulation of the trabecular meshwork in Sprague-Dawley rats. MAPKs were subsequently investigated over the following days for expression and activity alterations, using RT-PCR, immunohistochemistry and Western immunoblot.
p42/44 MAPK expression was unaltered after intraocular pressure (IOP) elevation, but there was a significant activation of this enzyme in ONH astrocytes after 6-24 h. Activated SAPK/JNK isoforms were present throughout healthy RGC axons but after IOP elevation or optic nerve crush, they both accumulated at the ONH, likely due to RGC axon transport disruption, and were subject to additional activation. p38 MAPK was expressed by a population of microglia which were significantly more populous following IOP elevation. However it was only significantly activated in microglia after 3 days, and then only in the ONH and optic nerve; in the retina it was solely activated in RGC perikarya.
In conclusion, each of the MAPKs showed a specific spatio-temporal expression and activation pattern in the retina, ONH and optic nerve as a result of IOP elevation. These findings likely reflect the roles of the individual enzymes, and the cells in which they reside, in the developing pathology following IOP elevation. These data have implications for understanding the mechanisms of ocular pathology in diseases such as glaucoma.
青光眼是一种主要的致盲原因,表现为与年龄相关的进行性视神经病变,伴有视网膜神经节细胞(RGC)丧失。有丝分裂原激活的蛋白激酶(MAPKs:p42/44 MAPK、SAPK/JNK、p38 MAPK)在各种视网膜疾病模型中被激活,可能有助于 RGC 死亡的机制。尽管 MAPKs 在视网膜病理的发展中起作用,但它们在视神经头(ONH)中的作用,即 RGC 轴突最初受到损伤的地方,在青光眼方面仍未得到探索。
通过在 Sprague-Dawley 大鼠的小梁网中激光诱导凝固来诱导慢性眼压升高(OHT),建立了一个代表青光眼的实验模型。随后,通过 RT-PCR、免疫组织化学和 Western 免疫印迹法,在接下来的几天内研究 MAPKs 的表达和活性变化。
眼压升高后 p42/44 MAPK 的表达没有改变,但在 6-24 小时后,ONH 星形胶质细胞中这种酶明显被激活。活化的 SAPK/JNK 同工型存在于健康的 RGC 轴突中,但在眼压升高或视神经挤压后,它们都在 ONH 处积累,可能是由于 RGC 轴突运输中断,并且受到额外的激活。p38 MAPK 由一群小胶质细胞表达,这些小胶质细胞在眼压升高后明显增多。然而,它仅在 3 天后在小胶质细胞中被显著激活,并且仅在 ONH 和视神经中;在视网膜中,它仅在 RGC 胞体中被激活。
总之,MAPKs 中的每一种在眼压升高后,在视网膜、ONH 和视神经中都表现出特定的时空表达和激活模式。这些发现可能反映了单个酶及其所在细胞在眼压升高后发展病理过程中的作用。这些数据对于理解青光眼等疾病中眼部病理的机制具有重要意义。